CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current assets
Cash	$ 12,453,767	$ 13,858,798
Prepaid drug product for testing	358,897	154,667
Other current assets	122,636	100,494
Total current assets	12,935,300	14,113,959
Fixed assets
Furniture, fixtures & equipment	123,410	123,410
Less Accumulated Depreciation	(20,568)	(10,284)
Property, Plant and Equipment, Net	102,842	113,126
Other assets
Technology licenses	2,500,374	2,500,374
Less Accumulated Amortization	(1,289,637)	(1,249,481)
Intangible Assets, Net (Excluding Goodwill), Total	1,210,737	1,250,893
TOTAL ASSETS	14,248,879	15,477,978
Current liabilities
Accounts payable	76,556	41,026
Accounts payable - related party	0	100,450
Accrued expense	539,668	253,445
Accrued expense - related party	0	67,050
Accrued license payments - related party	0	100,000
Total current liabilities	616,224	561,971
Long term debt	0	0
TOTAL LIABILITIES	616,224	561,971
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 3/31/15 and 12/31/14, respectively	89,763	89,763
Additional paid in capital	34,834,775	34,743,489
Accumulated deficit	(21,291,883)	(19,917,245)
Total shareholders' equity	13,632,655	14,916,007
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	$ 14,248,879	$ 15,477,978